8:00 - 19:00

Working hours MON. - FRI.

Drug makers say IP barriers not the bottleneck in boosting vaccine production By Reuters

ZURICH (Reuters) - Manufacturing capacity and shortages of ingredients are the main bottlenecks in expanding COVID-19 vaccine production, a drug industry group said on Tuesday, not the patents that some groups want removed. "IP (intellectual property) rights is not the issue. The bottlenecks are the capacity, the scarcity of raw materials, scarcity of ingredients, and it is about the know-how," Thomas...

Continue reading

Canada shares higher at close of trade; S&P/TSX Composite up 1.04% By Investing.com

Investing.com – Canada equities were higher at the close on Tuesday, as gains in the Healthcare, IT and Clean Technology sectors propelled shares higher. At the close in Toronto, the S&P/TSX Composite gained 1.04% to hit a new all time high. The biggest gainers of the session on the S&P/TSX Composite were Ballard Power Systems Inc (TSX:BLDP), which rose...

Continue reading

Exclusive: LG hopes to make new battery cells for Tesla in 2023 in U.S. or Europe – sources By Reuters

By Hyunjoo Jin SAN FRANCISCO (Reuters) - LG Energy Solution aims to build advanced battery cells for Tesla Inc electric vehicles in 2023 and is considering potential production sites in the United States and Europe, two people familiar with the matter told Reuters. Tesla has not yet agreed to a deal that would expand LG's role in its supply chain beyond...

Continue reading

Disney+ streaming service tops 100 million paid subscribers By Reuters

LOS ANGELES (Reuters) - Walt Disney (NYSE:DIS) Co's Disney+ streaming service has surpassed more than 100 million paying subscribers around the world, Chief Executive Bob Chapek said at the company's annual shareholder meeting on Tuesday. Chapek also said Disney hopes to reopen its California theme parks to limited attendance in late April. The parks were closed a year ago due...

Continue reading

EU’s Breton expects Johnson & Johnson vaccine OK soon, not worried about overall Q2 doses By Reuters

BRUSSELS (Reuters) - The European Union is likely to issue its approval for the anti-COVID-19 vaccine of Johnson&Johnson soon, Internal Market Commissioner Thierry Breton said, adding he was not worried reaching the overall EU goal for vaccines from all producers in the second quarter. "I have the feeling that EMA will give its authorisation within the next hopefully days or...

Continue reading

Irish broker Davy under regulator’s watch after ‘day of reckoning’ By Reuters

By Padraic Halpin DUBLIN (Reuters) - Davy Stockbrokers is under close regulatory scrutiny after a "day of reckoning" when it was fined a record 4.1 million euro ($4.9 million), a top Irish central bank official said. Ireland's largest stockbroker was fined last week after an inquiry into 16 of its staff who the regulator alleged sought to profit in 2014 by taking...

Continue reading

Global SPAC deal volumes this year surpass total for 2020 By Reuters

By Patturaja Murugaboopathy (Reuters) - Global blank-check deal volumes, or mergers through special purpose acquisition companies (SPACs), have surged to a record $170 billion this year, already outstripping last year's total of $157 billion, Refinitiv data showed. The record number of deals comes as SPACs are emerging as a popular IPO alternative for companies, providing startups with a path to going public with...

Continue reading

Peloton Soars on Australia Foray, Analyst Upgrade By Investing.com

By Dhirendra Tripathi Investing.com - (NASDAQ:PTON) jumped nearly 13% Tuesday, boosted by Monday’s announcement that it would expand into Australia. The stock rose almost $13, to $114, a trifle lower from the day’s high of $115.50 so far. Adding to the investor sentiment was an upgrade by MKM Partners analyst Rohit Kilkarni, who now has a ‘buy’ rating on the stock with a price...

Continue reading
en_GBEnglish